SPD-29088-89113
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 939 / CA
- Registered
- 2022-10-10
- Relationship
- Child or adolescent in my care
- Guardian
- XGF-64012-27231
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-28
Dose 1 — Pfizer-BioNTech
-
2022-07-30
Dose 2 — Pfizer-BioNTech
-
2022-10-10
Registered in v-safe
-
2022-10-10
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-08
- 2022-11-14
-
2022-11-21
Survey response — day 42, dose 3, dependentMedDRA: Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolFree text: Recent viral URIMedDRA releases: 2024-11 · check-in free text available
- 2023-01-09
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-28 | Pfizer-BioNTech | No |
| 2 | 2022-07-30 | Pfizer-BioNTech | No |
| 3 | 2022-10-10 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 42, dose 3, dependent
Symptoms: Recent viral URI
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release